These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 755852)
1. Effect of neurotensin on glucose and insulin portal blood levels in hyperglycemic rats. Farina JM; Celotti F; Motta M; Martini L J Endocrinol Invest; 1978 Apr; 1(2):179-81. PubMed ID: 755852 [TBL] [Abstract][Full Text] [Related]
2. Hyperglycemic effect of neurotensin. Yawata Y; Yamatani K; Tominaga M; Ebitani I; Hara M; Sasaki H Tohoku J Exp Med; 1984 Jun; 143(2):185-96. PubMed ID: 6147906 [TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia. Ukai M; Inoue I; Itatsu T Endocrinology; 1977 May; 100(5):1284-6. PubMed ID: 849724 [TBL] [Abstract][Full Text] [Related]
4. Involvement of cerebral neurotensin in hyperglycemic response caused by 2-deoxy-D-glucose in rats. Chun SJ; Niijima A; Shimizu K; Nagai K Neurosci Lett; 1995 Dec; 201(3):191-4. PubMed ID: 8786837 [TBL] [Abstract][Full Text] [Related]
5. Comparison of intraperitoneal, intraportal and intravenous insulin infusion. Poulsen JS; Smith M; Deckert M; Deckert T Acta Endocrinol (Copenh); 1980 Dec; 95(4):500-4. PubMed ID: 7006290 [TBL] [Abstract][Full Text] [Related]
6. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas. Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676 [TBL] [Abstract][Full Text] [Related]
7. Effect of intraventricular injection of neurotensin and other various bioactive peptides on plasma immunoreactive somatostatin levels in rat hypophysial portal blood. Abe H; Chihara K; Chiba T; Matsukura S; Fujita T Endocrinology; 1981 May; 108(5):1939-43. PubMed ID: 6163624 [TBL] [Abstract][Full Text] [Related]
8. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. Song SH; McIntyre SS; Shah H; Veldhuis JD; Hayes PC; Butler PC J Clin Endocrinol Metab; 2000 Dec; 85(12):4491-9. PubMed ID: 11134098 [TBL] [Abstract][Full Text] [Related]
9. Neurotensin hyperglycemia:evidence for histamine mediation and the assessment of a possible physiologic role. Nagai K; Frohman LA Diabetes; 1978 May; 27(5):577-82. PubMed ID: 648748 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094 [TBL] [Abstract][Full Text] [Related]
11. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601 [TBL] [Abstract][Full Text] [Related]
12. Potential endocrine effects of hypothalamic peptide "neurotensin" on pancreas in dogs. Kawanishi K; Goto A; Ishida T; Kawamura K; Nishina Y; Machida S; Yamamoto S; Ofuji T Acta Med Okayama; 1978 Aug; 32(4):301-8. PubMed ID: 153091 [TBL] [Abstract][Full Text] [Related]
13. Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels. Brown M; Vale W Endocrinology; 1976 Mar; 98(3):819-22. PubMed ID: 1261503 [TBL] [Abstract][Full Text] [Related]
14. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man. Jackson RA; Hamling JB; Blix PM; Sim BM; Hawa MI; Jaspan JB; Belin J; Nabarro JD J Clin Endocrinol Metab; 1986 Sep; 63(3):594-604. PubMed ID: 2874153 [TBL] [Abstract][Full Text] [Related]
15. Insulin levels after portal and systemic insulin infusion differ in a dose-dependent fashion. De Vos P; De Haan BJ; Vegter D; Hillebrands JL; Strubbe JH; Bruggink JE; Van Schilfgaarde R Horm Metab Res; 1998 Dec; 30(12):721-5. PubMed ID: 9930629 [TBL] [Abstract][Full Text] [Related]
16. Bolus administration of obestatin does not change glucose and insulin levels neither in the systemic nor in the portal circulation of the rat. Kiewiet RM; Gauna C; van Aken MO; van de Zande B; van der Lely AJ Peptides; 2008 Dec; 29(12):2144-9. PubMed ID: 18930090 [TBL] [Abstract][Full Text] [Related]
17. [The euglycemic insulin and hyperglycemic clamp technic. Methods for the determination of insulin sensitivity of tissues and glucose sensitivity of the B cell. A review]. Bratusch-Marrain PR Infusionsther Klin Ernahr; 1984 Feb; 11(1):4-10. PubMed ID: 6368388 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs. Ogihara N; Ebihara S; Kawamura W; Okamoto M; Sakai T; Takiguchi K; Morita T; Uchida R; Matsuyama Y; Hayashi Y; Arakawa Y; Kikuchi M Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E148-55. PubMed ID: 12388150 [TBL] [Abstract][Full Text] [Related]
19. Variation in the disappearance of unlabeled insulin from plasma: studies with portal and peripheral infusions. Tranberg KG; Thorell J Diabetes; 1979 Sep; 28(9):846-51. PubMed ID: 467811 [TBL] [Abstract][Full Text] [Related]
20. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs. Chap Z; Ishida T; Chou J; Lewis R; Hartley C; Entman M; Field JB J Clin Invest; 1985 Sep; 76(3):1174-81. PubMed ID: 3900134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]